Infection Control Essays

So what is Hepatitis B and what causes it? This is a liver disease that is normally spread through person to person via contact with the following: blood, semen, body fluids from a person with the virus. Most commonly, this disease unfortunately is spread from the mother to her

This Paper was written as an informative project about the Hepatitis B virus. The paper was written in a way that clearly discusses the specific causes, symptoms, treatments and prevention associated with the virus. The paper goes into details on ways to avoid contraction of this virus as well.

Symptoms of Hepatitis B may include: Abdominal pain, dark urine, fever, joint pain, loss of appetite, nausea and vomiting, weakness and fatigue, and jaundice. The causes of these symptoms can include by: Sexual contact, sharing of needles, accidental needle sticks at hospitals, and from mother to their child (MayoClinic). The type of medication you will get will depend on how badly your live may be damaged. Hepatitis B treatment moves quite slowly. Antiviral treatment is available to anyone who has Hepatitis B. They will need lifelong monitoring to see if anything worse happens to the liver and if the infection progresses (sahealth). People with Hepatitis B need lots of bed rest and plenty of fluids. People with acute Hepatitis B do not require treatment at all just home remedies, on the other hand people with chronic Hepatitis B do require a lot of

Chronic Hepatitis B is an infection that affects the liver, and if these disease is allow in it progression. It can cause fibrosis, cirrhosis, liver failure and hepatocellular carcinoma. It is a worldwide problem that does not have a cured. These virus has affected an estimated 400 billion people and these number is growing in a rapid rate. It will kill 25% of people who does not get treatment. In China, there are approximately 60% of the people have history of HBV infection, and about 7% to 10% of the population have the disease. They are in a high risk situation to have liver disease. Currently, there are few available drugs that can manage this epidemic, such drugs are interferon-alfa, nucleos(t)ide analogue polymerase inhibitors, but other drugs can be combined to help

Thus virus can also be transmitted through sharing needles or other drug equipment and from mother to baby at birth. While Hepatitis B can be an acute illness, it can become a chronic infection that is long term. Infants are most at risk for this infection because of transmission from an infected mother to baby the birth. Getting vaccinated can prevent the serious health issues that are associated with Hepatitis B.

The chronic hepatitis B infection is recognized by the presence of hepatitis B surface antigen (HBsAg) in the blood for six months or more. Also, detection

All people should be wary of this disease because it is common in most of the world and Estimates indicate that there are 240 million people are infected with hepatitis B so, This inflammation and is a global health problem prominent. It can cause chronic infection and to expose people to the risk of death due to cirrhosis of the liver strongly and liver cancer and The available vaccine for hepatitis B since 1982. This vaccine is 95% effective in preventing infection and the incidence of chronic disease and liver cancer caused by inflammation mentioned .[1] Hepatitis B is a serious liver infection caused by the Hepatitis B virus . Hepatitis B infection becomes chronic so , it will increases the risk of developing liver

Hepatitis B: Instigated by Hepatitis B virus and a chronic disease with duration lengthier than 6 months. Frequently lead to liver failure. Symptoms naturally appear 1-4 months after infection and young children may not display obvious symptoms. Symptoms comprise of dark urine, decrease hunger, nausea and vomiting, and yellowing of the skin or eyes.

Hepatitis B virus (HBV) is a DNA virus that affects the liver and belongs to the Hepadnaviridae group (Takkenberg, Weegink, Zaaijer, & Reesink, 2010). According to an article in Vox Sanguines, an international journal of transfusion medicine, (Takkenberg, Weegink, Zaaijer, & Reesink, 2010) “about 400 million people worldwide are chronically infected with HBV, and 2 billion people have serological evidence of past or present HBV infection”. HBV, formerly known as serum hepatitis (Huether & McCance, 2008), has eight genotypes (A-H) with genotype D being associated with viral or acute hepatitis B and prevalent mainly in Europe, North Africa, and the United States

Hepatitis B, from the family Hepadnavirdae, is a DNA virus which is particularly prevalent in developing countries in East Asia and sub-Saharan Africa. The virus targets the hepatocytes and replicates within the liver. HBV attaches to the hepatocyte using it’s virion S protein. This unique replication strategy involving an RNA intermediate and reverse transcription step often leads to a relatively high rates of mutation. Results of infection are variable and are influenced by factors such as sex, age and the state of immune system. For postnatal infections, incubation period usually lasts 60-80 days. Typically, the prodromal phase is defined by a transient rash which is followed thereafter by jaundice. Most patients recover after the onset

Hepatitis B is a significant global health problem. It is estimated that more than 350 million people worldwide have serological evidence of chronic HBV infection. During late 1960’s hepatitis outbreaks was reported among patients and staffs in hemodialysis centers. In 1972 - 1977, guidelines were published in UK &USA to reduce the spread of Hepatitis B virus in dialysis units. The Hepatitis vaccine made available to clinical use during 1980’s. With all of these measures the incidence rate of HBV is low, but it is still present in hemodialysis units. The prevalence of HBV across dialysis centers in Western Europe, Japan and the USA showed a range between 0-6.6percent, in Asia-pacific countries its around1.3% and 14.6 %. In the Middle East,

The hepatocarcinogenesis in HBV infection has been extensively analyzed, and multiple factors appear to play a role. A major factor is chronic necroinflammation and subsequent fibrosis/ liver cell proliferation. Nevertheless, HCC only occurs in a small proportion of HBsAg carriers. tocarcinogenic process involves the interplay between HBV and host hepatocytes, both genomes may contribute to the final pathogenic outcomes. apart from host factors, viral factors are very likely involved in HBV-related hepatocarcinogenesis.

Hepatitis B is a liver infection which is caused by Hepatitis B Virus (HBV). The hepatitis B virus attacks the liver and damage the liver. Hepatitis B is called as “Silent disease” because it doesn’t show any symptoms. Most adults are able to get recover from the hepatitis B virus but, some adults and baby are not able to recover from this Virus. The virus remain in the blood for a long time and this virus can transfer on others. The hepatitis B is infect on one third of people in the world. Hepatitis B is common in countries like China, India, Middle East, Africa, South America, parts of Europe. A person carrying Hepatitis B doesn’t get a job in China because the companies discriminate the infected people. Most graduates in China are unemployed because of the

Material & Methods: We evaluated 195 patients of hepatitis B virus infection over a period of 9 years & analysed their clinical & histological features and correlated them. Histological evaluation was done according to modified Ishak’s grading and Scheuer scoring system. Results: Patients were divided into age groups of < 40 & >

Hepatitis B is the inflammation of liver which may be self-limiting or leads to fibrosis, cirrhosis or even liver cancer known as hepatocellular carcinoma (WHO, 2016). Globally, Hepatocellular Carcinoma (HCC) is considered as a fifth and ninth most common cancer respectively in men and women (85-90% of the primary liver cancers) (Wallace et al., 2015). It